From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development
Learn how dosimetry, clinical pharmacology, pharmacometrics, QSP, and regulatory strategy support dose optimization for therapeutic…
Hunter Stephens, PhDJuly 17, 2026
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…
CertaraJuly 16, 2026
Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia
Explore how population pharmacokinetic and exposure–response modeling informed brexpiprazole dosing in Japanese patients with agitation…
CertaraJuly 16, 2026
When to conduct hepatic impairment studies and when modeling may be enough
How to decide if a hepatic impairment study is required, choose the right study design,…
Zoe BarterJuly 13, 2026
Dosimetry for radiopharmaceutical therapy: From measurement to dose justification
Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…
Hunter Stephens, PhDJuly 7, 2026
Population PK Modeling Supporting the Aripiprazole Two-Injection Start Regimen in Japanese Patients
Learn how population PK modeling and simulation supported a regulatory strategy for a simplified aripiprazole…
Danielle PillsburyJuly 7, 2026
